Killer cell lectin-like receptor G1 deficiency significantly enhances survival after Mycobacterium tuberculosis infection

Infection and Immunity

Volumn 81, Issue 4, 2013, Pages 1090-1099

  Cyktor, Joshua C ^a   Carruthers, Bridget ^a   Stromberg, Paul ^a   Flaño, Emilio ^a,b   Pircher, Hanspeter ^c   Turnera, Joanne ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LYMPHOCYTE RECEPTOR; NATURAL KILLER CELL RECEPTOR G1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; EX VIVO STUDY; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION; INFECTION CONTROL; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; BACTERIAL LOAD; CD4-POSITIVE T-LYMPHOCYTES; INTERFERON-GAMMA; LUNG; MICE; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, IMMUNOLOGIC; SURVIVAL ANALYSIS; TUBERCULOSIS;

EID: 84875495249     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01199-12     Document Type: Article

References (35)

1. Blaser C, Kaufmann M, Pircher H. 1998. Virus-activated CD8 T cells and lymphokine-activated NK cells express the mast cell functionassociated antigen, an inhibitory C-type lectin. J. Immunol. 161:6451-6454.
2. Voehringer D, Blaser C, Brawand P, Raulet DH, Hanke T, Pircher H. 2001. Viral infections induce abundant numbers of senescent CD8 T cells. J. Immunol. 167:4838-4843.
3. Hanke T, Corral L, Vance RE, Raulet DH. 1998. 2F1 antigen, the mouse homolog of the rat "mast cell function-associated antigen", is a lectin-like type II transmembrane receptor expressed by natural killer cells. Eur. J. Immunol. 28:4409-4417.
4. Gründemann C, Bauer M, Schweier O, von Oppen N, Lassing U, Saudan P, Becker KF, Karp K, Hanke T, Bachmann MF, Pircher H. 2006. Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J. Immunol. 176:1311-1315.
5. Ito M, Maruyama T, Saito N, Koganei S, Yamamoto K, Matsumoto N. 2006. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J. Exp. Med. 203:289-295.
6. Li Y, Hofmann M, Wang Q, Teng L, Chlewicki LK, Pircher H, Mariuzza RA. 2009. Structure of natural killer cell receptor KLRG1 bound to Ecadherin reveals basis for MHC-independent missing self recognition. Immunity 31:35-46.
7. Gründemann C, Schwartzkopff S, Koschella M, Schweier O, Peters C, Voehringer D, Pircher H. 2010. The NK receptor KLRG1 is dispensable for virus-induced NK and CD8- T-cell differentiation and function in vivo. Eur. J. Immunol. 40:1303-1314.
8. Rosshart S, Hofmann M, Schweier O, Pfaff AK, Yoshimoto K, Takeuchi T, Molnar E, Schamel WW, Pircher H. 2008. Interaction of KLRG1 with E-cadherin: new functional and structural insights. Eur. J. Immunol. 38: 3354-3364.
9. Schwartzkopff S, Grundemann C, Schweier O, Rosshart S, Karjalainen KE, Becker KF, Pircher H. 2007. Tumor-associated E-cadherin mutations affect binding to the killer cell lectin-like receptor G1 in humans. J. Immunol. 179:1022-1029.
10. Henson SM, Franzese O, Macaulay R, Libri V, Azevedo RI, Kiani- Alikhan S, Plunkett FJ, Masters JE, Jackson S, Griffiths SJ, Pircher HP, Soares MV, Akbar AN. 2009. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8- T cells. Blood 113:6619-6628.
11. Robbins SH, Nguyen KB, Takahashi N, Mikayama T, Biron CA, Brossay L. 2002. Cutting edge: inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells. J. Immunol. 168:2585-2589.
12. Henao-Tamayo M, Irwin SM, Shang S, Ordway D, Orme IM. 2011. T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis. Tuberculosis (Edinb) 91:308-313.
13. Reiley WW, Shafiani S, Wittmer ST, Tucker-Heard G, Moon JJ, Jenkins MK, Urdahl KB, Winslow GM, Woodland DL. 2010. Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U. S. A. 107:19408-19413.
14. Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, Blum HE, Pircher H, Thimme R. 2010. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8- T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog. 6:e1000947.doi:10.1371/journal.ppat .1000947.
15. Vesosky B, Flaherty DK, Turner J. 2006. Th1 cytokines facilitate CD8- T-cell-mediated early resistance to infection with Mycobacterium tuberculosis in old mice. Infect. Immun. 74:3314-3324.
16. Beamer GL, Flaherty DK, Vesosky B, Turner J. 2008. Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice. Clin. Vaccine Immunol. 15: 474-483.
17. Beamer GL, Flaherty DK, Assogba BD, Stromberg P, Gonzalez-Juarrero M, de Waal Malefyt R, Vesosky B, Turner J. 2008. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J. Immunol. 181:5545-5550.
18. Rottinghaus EK, Vesosky B, Turner J. 2009. Interleukin-12 is sufficient to promote antigen-independent interferon-gamma production by CD8 T cells in old mice. Immunology 128:e679-e690.
19. Vesosky B, Rottinghaus EK, Stromberg P, Turner J, Beamer G. 2010. CCL5 participates in early protection against Mycobacterium tuberculosis. J. Leukoc. Biol. 87:1153-1165.
20. Kang DD, Lin Y, Moreno JR, Randall TD, Khader SA. 2011. Profiling early lung immune responses in the mouse model of tuberculosis. PLoS One 6:e16161. doi:10.1371/journal.pone.0016161.
21. Medina E, North RJ. 1998. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 93:270-274.
22. Russell-Goldman E, Xu J, Wang X, Chan J, Tufariello JM. 2008. A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes. Infect. Immun. 76:4269-4281.
23. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM, Ghilardi N, deSauvage F, Cooper AM. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigenspecific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175:788-795.
24. Bengsch B, Spangenberg HC, Kersting N, Neumann-Haefelin C, Panther E, von Weizsacker F, Blum HE, Pircher H, Thimme R. 2007. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8- T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J. Virol. 81:945-953.
25. Thimme R, Appay V, Koschella M, Panther E, Roth E, Hislop AD, Rickinson AB, Rowland-Jones SL, Blum HE, Pircher H. 2005. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J. Virol. 79:12112-12116.
26. Beyersdorf N, Ding X, Tietze JK, Hanke T. 2007. Characterization of mouse CD4 T cell subsets defined by expression of KLRG1. Eur. J. Immunol. 37:3445-3454.
27. Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. 2004. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 173:2660-2668.
28. Noss EH, Harding CV, Boom WH. 2000. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell Immunol. 201:63-74.
29. Chang ST, Linderman JJ, Kirschner DE. 2005. Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class IImediated antigen presentation by macrophages. Proc. Natl. Acad. Sci. U. S. A. 102:4530-4535.
30. Tessmer MS, Fugere C, Stevenaert F, Naidenko OV, Chong HJ, Leclercq G, Brossay L. 2007. KLRG1 binds cadherins and preferentially associates with SHIP-1. Int. Immunol. 19:391-400.
31. Heffner M, Fearon DT. 2007. Loss of T cell receptor-induced Bmi-1 in the KLRG1(-) senescent CD8(-) T lymphocyte. Proc. Natl. Acad. Sci. U. S. A. 104:13414-13419.
32. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF. 2003. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423:302-305.
33. Lessard J, Sauvageau G. 2003. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255-260.
34. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. 2003. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425:962-967.
35. van der Lugt NM, Domen J, Linders K, van Roon M, Robanus- Maandag E, te Riele H, van der Valk M, Deschamps J, Sofroniew M, van Lohuizen M. 1994. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 8:757-769.